Clinical Research Coordinator II - VANGUARD (TAMC)

Federallabs; Honolulu (HI); On-site; USD 65,000 - 90,000; Full time

Job summary

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is seeking a Clinical Research Coordinator II to join our team at Tripler Army Medical Center in Honolulu, Hawaii. The CRC will be essential for patient recruitment, consent, specimen handling, and daily study operations within MCCRP studies.

This 100% on-site position requires the ability to support DoD-sponsored trials and may involve cross-training on additional protocols to meet operational needs.

Qualifications

• Clinical Research Coordinator role supporting Vanguard Study and MCCRP studies.
• Experience coordinating clinical research activities is desirable.
• Must be able to work on-site at Tripler Army Medical Center, Honolulu, HI.

Responsibilities

• Recruit and consent participants for Vanguard Study and MCCRP protocols.
• Process and ship specimens and manage basic regulatory tasks.
• Maintain study documentation and assist with regulatory compliance; potential cross-training on other protocols.

Job description

Join the HJF Team!

HJF is seeking a Clinical Research Coordinator II to join our team at Tripler Army Medical Center, Honolulu, Hawaii. The successful candidate willplay a crucial role in clinical research activities, including patient recruitment, consent processes, specimen processing and shipping, study documentation and basic regulatory management for Murtha Cancer Center Research Program (MCCRP) studies. This position is 100% on site.

Note: Due to clearance requirements this position is only able to consider U.S. Citizens.

The Department of Defense (DoD), represented by Uniformed Services University (USU)/MCCRP, is participating in the National Cancer Institute (NCI) Cancer Screening Research Network (CSRN). The CSRN consists of seven civilianhealthcare systems, the Department of Veterans Affairs and the DoD. The first study the CSRN is undertaking is a pilot study, known as the Vanguard Study: Testing a New Way to Screen for Cancer, which will enroll approximately 18,000 total participants over four years. Multi-Cancer Detection (MCD) tests claim to screen for several types of cancers using only a blood sample. The Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial. The results of the Vanguard Study will inform the design of a larger randomized controlled trial involving about 225,000 people. The Clinical Research Coordinator (CRC) is anticipated to primarily support the conduct and day-to-day activities of the Vanguard Study; however, the CRC may also be cross training on additional research protocols to provide coverage and support to other studies as operational needs arise.

This position will be in support of the John P. Murtha Cancer Center, whose head office is located at the Walter Reed National Military Medical Center, in Bethesda, Maryland. The Murtha Cancer Center is a modern, patient-centric, tri-service military healthcare facility. Its comprehensive core of military and civilian oncologists and other cancer-trained clinicians and researchers provide multidisciplinary cancer-care delivery and patient-family support services. Our Cancer Center, the only DoD Cancer Center of Excellence within the Military Health System, offers its patients access to innovative cancer diagnostic and treatment technologies.

The Henry M. Jackson Foundation for the Advancement of Military Medicine (HJF) is a nonprofit organization dedicated to advancing military medicine. We serve military, medical, academic and government clients by administering, managing, and supporting preeminent scientific programs that benefit members of the armed forces and civilians alike. Since its founding in 1983, HJF has served as a vital link between the military medical community and its federal and private partners. HJF's support and administrative capabilities allow military medical researchers and clinicians to maintain their scientific focus and accomplish their research goals.